Edgewell (EPC) Q3 2026 Earnings Call Transcript
Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% on a 1.1% organic increase. Adjusted EPS was $0.72, flat year over year. Adjusted EBITDA fell to $78.9 million. Management cited North America organic growth of 3.0% and a 1.4% international decline from Middle East and supply disruptions. Full-year organic sales guidance is flat to +0.5%, adjusted EPS $1.80-$2.00.
How this was made
The 30-second read
Why it matters
Key decision inputs are the narrowed FY2026 guidance ranges (organic net sales flat to +0.5%, adjusted EPS $1.80 to $2.00, adjusted EBITDA $250M to $260M, and adjusted free cash flow $80M to $110M excluding divestiture impacts) plus quantified headwinds (160 bps inflation and tariffs, international organic sales -1.4% tied to Middle East conflict and supply disruptions) and restructuring costs (~$92M).
Market read
This transcript is a guidance and driver update that can move earnings models through FY2026 EPS, EBITDA, and free cash flow ranges, with particular sensitivity to international supply normalization and promotional/mix-driven gross margin.
What to watch
Wet Shave manufacturing consolidation is described as creating temporary international supply disruption; traders should monitor whether the projected disruption timing aligns with the Q4 acceleration narrative and whether restructuring costs ($92M) translate into faster margin recovery than the guidance implies.
Background
Edgewell Personal Care (EPC) discussed Q3 FY2026 performance after the Feminine Care divestiture and while consolidating Wet Shave manufacturing across its network.
Ticker impact
Edgewell reported Q3 FY2026 net sales of $570.1M, adjusted EPS $0.72, and narrowed full-year guidance amid Wet Shave manufacturing consolidation.
Moderate volatility likely around margin and FCF guidance, with upside if international supply disruption resolves faster than implied.
The transcript provides concrete quarterly results plus full-year ranges for organic sales, adjusted EPS, EBITDA, and free cash flow, and quantifies margin headwinds and restructuring costs. However, it is a call transcript and may not be a first-time disclosure versus already-released earnings materials.
Market effects
Personal care and branded consumer staples traders may reprice peers’ margin and demand assumptions based on Edgewell’s mix, promo intensity, and supply-chain disruption commentary.
International organic sales weakness is explicitly tied to Middle East conflict and temporary Europe and Latin America supply disruptions, which can affect regional sentiment for similar supply-chain exposed brands.
Tariff and input-cost inflation headwinds quantified (160 bps) may influence broader cost-of-goods expectations for consumer packaged goods with similar commodity exposure.
Counterpoint
The organic growth re-acceleration could be more durable than the company’s cautious international framing suggests, especially if distribution gains and Sun/Skin momentum offset promo/mix pressure.
Key entities
- companyEdgewell Personal Care Company
Reported Q3 FY2026 results and provided narrowed FY2026 guidance, including margin and cash flow outlook tied to restructuring and supply-chain disruption.
- executiveRod Little
CEO who highlighted Wet Shave manufacturing consolidation as the largest operational initiative and discussed Cremo and Hawaiian Tropic brand momentum.
- executiveFrancesca Weissman
CFO who quantified inflation/tariff headwinds and attributed international organic sales decline to Middle East conflict and temporary supply disruptions.
